MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s40814-025-01731-4

Медицинская библиотека · Pilot and feasibility studies · 2025

The SQUEEZE pilot trial: a trial to determine whether septic shock reversal is quicker in pediatric patients randomized to an early goal directed fluid-sparing strategy vs. usual care.

Parker Melissa J, Choong Karen, Fox-Robichaud Alison, Liaw Patricia C, Thabane Lehana, Canadian Critical Care Trials Group and the Canadian Critical Care Translational Biology Group

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

The overall objective of our research is to determine in children with septic shock whether the use of a fluid-sparing strategy results in improved clinical outcomes without an increased risk of adverse events compared to usual care. The specific objective of this pilot randomized controlled trial was to evaluate the feasibility of a definitive multicenter trial to answer our research question.

DESIGN

Pragmatic, 2-arm, parallel group, open-label, prospective pilot randomized controlled trial including a nested biosample-based translational study.

SETTING

Pediatric tertiary care center.

PATIENTS: Children aged 29 days to <18 years of age presenting to the emergency department or admitted to an inpatient ward (including the PICU) with suspected or confirmed septic shock and a need for ongoing resuscitation.

INTERVENTIONS: Fluid-sparing vs. usual care resuscitation strategy continued until shock reversal. The fluid-sparing intervention comprised instructions to restrict fluid bolus therapy in conjunction with early initiation and/or preferential use of vasoactive medication support as a strategy to spare fluid while targeting the hemodynamic goals specified in the American College of Critical Care Medicine Surviving Sepsis Guidelines. The usual care strategy did not limit the use of fluid bolus therapy.

MEASUREMENTS AND MAIN

RESULTS

Fifty-three were randomized to usual care (n = 27) or fluid-sparing (n = 26). Fifty-one participants were available for primary outcome analysis. Primary feasibility outcomes related to participant enrollment and protocol adherence. Enrollment rate was 1.8 (51/29); 95% confidence interval [CI]: 1.3-2.3 participants/month. Study procedures were implemented in 49/51 (96.1%), 95% CI: 86.5-99.5% participants within 1 h of randomization in a median (interquartile range [IQR]) of 8 (5, 15) minutes. The protocol required the use of an exception to consent process and consent for ongoing participation was 48/51 (94.1%), 95% CI: 83.8-98.8%. There were no serious adverse events.

CONCLUSIONS

We concluded the large multicenter SQUEEZE trial feasible to conduct.

TRIAL REGISTRATION: ClinicalTrials.gov [NCT01973907]. Registered October 27, 2013, https://clinicaltrials.gov/study/NCT01973907 .

Для цитирования: Parker Melissa J, Choong Karen, Fox-Robichaud Alison, Liaw Patricia C, Thabane Lehana, Canadian Critical Care Trials Group and the Canadian Critical Care Translational Biology Group. The SQUEEZE pilot trial: a trial to determine whether septic shock reversal is quicker in pediatric patients randomized to an early goal directed fluid-sparing strategy vs. usual care.. Pilot and feasibility studies. 2025. DOI: 10.1186/s40814-025-01731-4.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.